Investors Fight Keryx Bid To Ditch Kidney Drug Stock Case
Shareholders of Keryx Biopharmaceuticals Inc. told a Massachusetts federal judge Wednesday that the drug company's latest attempt to ditch claims it hid potential snags in the manufacturing of its drug Auryxia...To view the full article, register now.
Already a subscriber? Click here to view full article